MYLAN 6260 MYLAN 6260 Pill: pink, capsule/oblong, 18mm
The pill with imprint MYLAN 6260 MYLAN 6260 (Pink, Capsule/Oblong, 18mm) has been identified as Propranolol Hydrochloride Extended-Release 160 mg and is used for Benign Essential Tremor, Aortic Stenosis, Migraine Prevention, Angina, and Chronic Migraine. It belongs to the drug classes group II antiarrhythmics, non-cardioselective beta blockers and is not a controlled substance.
Images for MYLAN 6260 MYLAN 6260
Propranolol Hydrochloride Extended-Release
- Imprint
- MYLAN 6260 MYLAN 6260
- Strength
- 160 mg
- Color
- Pink
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group II antiarrhythmics, Non-cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6260 (Discontinued)
- Inactive Ingredients
-
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
dibutyl sebacate,
ethylcellulose,
hydroxypropyl cellulose,
hypromelloses,
microcrystalline cellulose,
polyethylene glycol,
magnesium silicate,
FD&C Blue No. 1,
gelatin,
sodium lauryl sulfate,
titanium dioxide,
D&C Red No. 28,
FD&C Red No. 40,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
See also:
More about propranolol
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,389)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: group II antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Inderal, Hemangeol, InnoPran XL, Inderal XL
Professional resources
- Propranolol monograph
- Propranolol (FDA)
- Propranolol Injection (FDA)
- Propranolol Oral Solution (FDA)
- Propranolol Tablets (FDA)
Other brands
Inderal, Inderal LA, Hemangeol, InnoPran XL, Inderal XL
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.